K2 HealthVentures provides growth capital, venture debt, and other structured financing solutions to commercial-stage and late-stage healthcare companies. Their focus spans biopharmaceuticals, medical devices, diagnostics, and digital health, offering non-dilutive or minimally dilutive capital.
Portfolio
3
Fund Size
$200M
Top Stage
Growth
Last 12 Mo
1
Team
AA
Anup Arora
Founding Managing Director & CIO
AS
Austin Sherwindt
Managing Director
NS
Nimesh Shah
Managing Director
DA
Derek Abel
Principal
SB
Sahil Bahri
Senior Associate
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Apella | Series B | $80M | Jan 2026 |
| Evergreen Nephrology | Growth | $130M | Jan 2025 |
| HarmonyCares | Growth | $200M | Jul 2024 |
Top Co-Investors
Oak HC/FT2 shared
Casdin Capital1 shared
Operator Partners1 shared
General Catalyst1 shared
McKesson Ventures1 shared
Rubicon Founders1 shared
Valtruis1 shared
HLM Venture Partners1 shared
Last updated: 1 March 2026